{"database": "openregs", "table": "documents", "rows": [["FDA-1995-N-0225-0003", "FDA", "FDA-1995-N-0225", "Reference 1 - Letter dated June 20, 1992, from R. W.Soller, Nonprescription Drug Manufacturers Association, to W. E. Gilbertson, FDA, in OTC Vol. 190036, Docket No. 95N 0062, Dockets Management Branch.", "Supporting & Related Material", "Background Material", "2017-02-01T05:00:00Z", 2017, 2, null, null, "2024-07-30T15:17:55Z", null, 0, 0, "09000064824a4be6"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1995-N-0225-0003"], "units": {}, "query_ms": 79.43980302661657, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}